Skip to main content
. 2020 Jul;21(7):1977–1986. doi: 10.31557/APJCP.2020.21.7.1977

Table 3.

Percentage of Cell Viability and Inhibition of HeLa, SiHa and CaSki Cell Lines by WE at 24h Calculated IC50 Value

Concentration of WE (µg/mL) Cell viability ± SD (%)
Inhibition ± SD (%)
IC50 ± SD value of WE
HeLa SiHa CaSki HeLa SiHa CaSki HeLa SiHa CaSki
50 78.19±6.75b 81.57±7.67b 74.12±6.89b 21.81±2.34f 18.43±1.75e 25.88±2.59f 220.34±17.23 248.21±19.67 152.66±11.44
100 68.67±6.12c 73.88±6.99b 62.24±5.90c 31.33±3.11e 26.12±2.34d 37.76±3.65e
150 61.44±6.11c 56.10±5.58c 50.77±4.98d 38.56±3.78d 34.19±3.90c 49.23±4.15d
200 53.11±4.22d 61.00±6.01c 42.24±4.78e 46.89±4.89c 39.00±4.02c 57.76±4.90c
250 32.10±3.87e 48.77±4.05d 24.44±2.35e 67.90±6.01b 51.23±5.56b 75.56±6.45b
Control (negative) 100a 100a 100a 0 0 0
Positive control (Adriamycin 5µg/mL) 1.09±0.55f 1.89±0.65e 0.11±0.66f 98.91±9.22a 98.11 ±9.17a 99.89 ±10.12a

Note: Each data is Mean± SD (p<0.05) of three independent experiments. Same letter in the same row indicates statistically no different but different letter indicates they are statistically different as per Duncan analysis (p=0.05 level)